Roy Doumani, a survivor of prostate cancer, is a native of Los Angeles. He graduated from UCLA with a degree in Business and Finance and received a law degree from the University of Southern California. He is a member of the California NanoSystems Institute  (CNSI) Advisory and Oversight Board. Mr. Doumani holds the position of Professor of Molecular and Medical Pharmacology  at the David Geffen School of Medicine  at UCLA. He also serves as co-chairman of the Zhejiang California NanoSystems Institute (ZCNI) and is chairman of the Business Advisory Board for the governor of Zhejiang Province, China.
Mr. Doumani has been active in the development of industrial, commercial and residential real estate. He also has business interests in Asia and holds an equity position in the first joint venture bank in the PRC, Xiamen International Bank (XIB), at which he serves as Vice Chairman. Mr. Doumani has been involved with numerous financial institutions: he was Founder and Director of First Los Angeles Bank; he was Chairman of First Interstate Bank of Hawaii; he was Director of HonFed Bank; he was Chairman of World Trade Bank in Los Angeles. Mr. Doumani has served as a board member and advisor to companies in the United States, Asia and Europe, including Vice Chairman of CTI (CTMI NASDAQ-listed). In addition to his business interests, Mr. Doumani serves as a member of the advisory boards of both RAND’s Center for Middle East Public Policy and its Center for Asia Pacific Policy. He is a member of the UCLA  Board of Governors and serves on the UCLA Foundation’s investment committee. He has established two endowed chairs at UCLA, one in the Department of Bioengineering and one in the Department of Urological Oncology.